Delivery Order SPE2DB22D3501-SPE2DB24FUS70
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 100 capsules of the pharmaceutical Revlimid 10 mg, with a potential value of $213,074.21. The delivery order is part of a larger indefinite delivery contract with DLA Troop Support Medical for Amerisourcebergen to provide pharmaceuticals and medical supplies to support military treatment...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $56,490.52 firm-fixed-price contract is for the delivery of Revlimid 10 mg capsules and has an ultimate completion date of January 22, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $49,926.80. The order is for REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of October 9, 2024 and is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $27,859.78, is for the delivery of REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product, with a performance period through April 3, 2024. This delivery order is issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $12,329.16 to AmerisourceBergen Drug Corp for the supply of Revlimid 5 mg capsules (28-count) under a Firm Fixed Price contract with an ultimate completion date of September 3, 2025. This non-set-aside award was competitively awarded and represents a direct fulfillment of pharmaceutical supply needs for federal medical procurement, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $41,659.75 firm fixed price delivery order is for the supply of REVLIMID 10 MG CAPSULE 28S, a specialty drug product. The award has an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at approximately $51.7K to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units). This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive procurement executed under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $53,251.31 for Revlimid 15 mg capsules (100-count units) on August 28, 2025, with an ultimate completion date of September 19, 2025. The contract employs firm fixed price pricing and carries no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of pharmaceutical products. The award has a ceiling value of $27,859.78 and a period of performance through April 15, 2024. Amerisourcebergen Drug Corp is providing REVLIMID 10 MG CAPSULE 28S, a branded prescription medication, to support military treatment programs and facilities. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $24,658.32 to AmerisourceBergen Drug Corp for 28-count bottles of Revlimid 5 mg capsules under a firm fixed price contract. The award was made on July 14, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUS70Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation. The order, valued at $27,859.78, is for the supply of 28-count capsules of the pharmaceutical Revlimid 10 mg. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is one of multiple awards to Amerisourcebergen Drug Corp under an Indefinite Delivery Contract (IDC) with DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as Amerisourcebergen Drug Corp's primary contract vehicle for providing pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.9k | 2/27/24 |